LSBio
SLC22A1 Antibody (aa511-539)

SLC22A1 Antibody western blot of HepG2 cell line lysates (35 ug/lane). The SLC22A1 antibody detected the SLC22A1 protein (arrow).

SLC22A1 Antibody (aa511-539)

Primary AntibodyLSBio Guarantee
Antibody:Rabbit Polyclonal
Applications:Immunohistochemistry (general), Western Blot
Reactivity:Human
Format:Liquid
See all Human SLC22A1 antibodies →
$401.00each
Catalog Number: LS-C161155-400

For bulk orders or custom formulations:

Request a Quote

Overview

Description
SLC22A1 antibody LS-C161155 is an unconjugated rabbit polyclonal antibody to human SLC22A1 (aa511-539). Validated for WB. Cited in 2 publications.
Application
IHC, WB
Reactivity
Hu
Intended Use
Research Use Only
Guarantees
This antibody carries the LSBio 100% Guarantee.
Category
Antibodies > Primary Antibodies > Polyclonal Antibodies
Alternative Names
HOCT1 | OCT1 | Oct1_cds | Organic cation transporter 1 | SLC22A1
Recommended Dilution: WB
1:1000
UniProt Number
O15245
SwissProt
O15245

Target

Target
Human SLC22A1
Antigen Species
Human
Epitope
This SLC22A1 antibody is generated from rabbits immunized with a KLH conjugated synthetic peptide between 511-539 amino acids from the C-terminal region of human SLC22A1.
Gene Name
SLC22A1

Antibody

Host Species
Rabbit
Clonality
Polyclonal

Immunogen

Immunogen
KLH conjugated synthetic peptide between 511-539 amino acids from the C-terminal region of human SLC22A1
Immunogen Type
Synthetic Peptide (Linear)

Format

Conjugate/Label
Unconjugated
Format
Liquid
Formulation
PBS, 0.09% Sodium Azide
Concentration
0.4 mg/mL
Volume
400 Microliter
Preservative
Yes

Storage & Handling

Storage Conditions
Maintain refrigerated at 2°C to 8°C for up to 6 months. For long term storage store at -20°C.
Recommended Storage Buffer
PBS

The lack of the organic cation transporter OCT1 at the plasma membrane of tumor cells precludes a positive response to sorafenib in patients with hepatocellular carcinoma. Geier A, Macias RI, Bettinger D, Weiss J, Bantel H, Jahn D, Al-Abdulla R, Marin JJ. Oncotarget. 2017 February;8:15846-15857.

PubMed: 28178663 · PMC: PMC5362528


The Role of the Carnitine/Organic Cation Transporter Novel 2 in the Clinical Outcome of Patients With Locally Advanced Esophageal Carcinoma Treated With Oxaliplatin. Dongfeng Sun, Qingfa Chen, Zhibo Gai, Fengxia Zhang, Xiaoqing Yang, Wensi Hu, Chengyu Chen, Guangjie Yang, Severin Hörmann, Gerd A Kullak-Ublick, Michele Visentin. Frontiers in pharmacology. 2021 Sep;12:684545.

PubMed: 34603016 · PMC: PMC8481660

Request SDS/MSDS

To request an SDS/MSDS form for this product, please contact our Technical Support department at: technical@vectorlabs.com.